Skip to content

The Impact of Total Body Skin Examination on Skin Cancer Detection

The Impact of Total Body Skin Examination on Skin Cancer Detection

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00765193
Acronym
TBSE
Enrollment
14381
Registered
2008-10-02
Start date
2008-05-31
Completion date
2009-05-31
Last updated
2010-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Basal Cell Carcinoma, Melanoma, Merkel Cell Carcinoma, Skin Cancer, Squamous Cell Carcinoma

Brief summary

This will be a study where all patients will undergo a two-step procedure: Step 1 - Physicians examine the problem area of skin ONLY and record result. Step 2 - Physicians perform TBSE and record result. Eventual lesions suggestive of melanoma and non-melanoma skin cancers will be recorded after step 1 or step 2 examination and will be finally biopsied and histopathologically diagnosed. Exceptions to biopsy may include patients with multiple non-melanoma skin cancers (e.g. actinic keratoses or basal cell carcinomas). Each center will be provided with an electronic data sheet for patients record, or alternatively, with a paper record form. Endpoints of the study are new parameters concerning the standard of care for skin cancer screening. We expect to conclude that TBSE enables clinicians discovering an increased number of skin cancers thus resulting in earlier detection.

Detailed description

Clinicans performed a two-step examination for skin cancer, with clinical examination of individual lesions was aided by the use of dermoscopy, as needed. In the first step, physicians performed inspection of problem areas and uncovered areas only, and lesions suggestive of melanoma or non-melanoma skin cancer were noted. In the second step, TBSE was performed. Following both examinations, lesions suggestive of melanoma or non-melanoma skin cancer were excised or biopsied. Histopathologic diagnosis was recorded for each of the biopsied or excised lesions. Statistical analysis: We calculated absolute risks as the proportion of individuals with the target disease divided by all individuals at risk. The number needed to examine was calculated by dividing the individuals at risk by the numbers of individuals with the target disease. Confidence intervals for proportions were calculated using standard formulas based on the binomial distribution. Chi square tests were used for comparison of proportions. Continuous variables are presented as mean and standard deviation (SD) unless otherwise specified. For univariate and multivariate analyses we used odds ratios derived from logistic regression to estimate relative risks and their confidence intervals. All p-values reported are 2-tailed. Statistical significance is defined as P \<0.05. Statistical analysis was performed using SPSS software, version 16.0 (SPSS, Chicago, Ill, US).

Interventions

OTHERInspection of covered areas

Clinicans performed a two-step examination for skin cancer, with clinical examination of individual lesions was aided by the use of dermoscopy, as needed. In the first step, physicians performed inspection of problem areas and uncovered areas only, and lesions suggestive of melanoma or non-melanoma skin cancer were noted. In the second step, TBSE was performed. Following both examinations, lesions suggestive of melanoma or non-melanoma skin cancer were excised or biopsied. Histopathologic diagnosis was recorded for each of the biopsied or excised lesions.

Sponsors

Medical University of Graz
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 95 Years
Healthy volunteers
Yes

Inclusion criteria

* Consecutive, unselected adult (18 years or more) patients with any skin disorders. Skin disorder must be localized on a limited body area and should NOT require total body skin examination (TBSE) to be diagnosed and/or treated.

Exclusion criteria

* Patients who ask for or need TBSE as the main reason for consultation. A patient must be also excluded if a significant part of the body should be undressed for diagnosis and/or treatment (i.e. if the shirt or trousers should be removed for diagnosis and/or treatment, then the patient must be excluded). * patients under the age of 18 years. * patients who do not agree to get TBSE.

Design outcomes

Primary

MeasureTime frame
Number of Participants With Suspicious Tumors Detected After Inspection of Problem Area and Inspection of the Full Body.one year

Secondary

MeasureTime frame
Whether a Systematic Screening is Related to a Higher Number of Unnecessary Excisions of Benign Skin Tumors Detected During the Screening.one year

Countries

Austria

Participant flow

Participants by arm

ArmCount
Skin Cancer Screening
Physicians examine, first, the problem area of skin and record result, and second, the full body and record result.
14,381
Total14,381

Baseline characteristics

CharacteristicSkin Cancer Screening
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
3354 Participants
Age, Categorical
Between 18 and 65 years
11027 Participants
Age Continuous49.4 years
STANDARD_DEVIATION 18.4
Region of Enrollment
Argentina
1001 participants
Region of Enrollment
Australia
43 participants
Region of Enrollment
Austria
997 participants
Region of Enrollment
Brazil
2010 participants
Region of Enrollment
France
999 participants
Region of Enrollment
Italy
7381 participants
Region of Enrollment
Netherlands
787 participants
Region of Enrollment
Spain
179 participants
Region of Enrollment
Turkey
984 participants
Sex: Female, Male
Female
7984 Participants
Sex: Female, Male
Male
6397 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 0
serious
Total, serious adverse events
0 / 0

Outcome results

Primary

Number of Participants With Suspicious Tumors Detected After Inspection of Problem Area and Inspection of the Full Body.

Time frame: one year

Population: From a population of patients with various skin conditions, participants were considered for inclusion only if aged 18 years or more, and if suffering from focused skin complaints. Patients with diffuse skin complaints were excluded.

ArmMeasureValue (NUMBER)
Problem Area ExaminationNumber of Participants With Suspicious Tumors Detected After Inspection of Problem Area and Inspection of the Full Body.810 participants
Full Body ExaminationNumber of Participants With Suspicious Tumors Detected After Inspection of Problem Area and Inspection of the Full Body.631 participants
Comparison: The primary outcomes were the calculation of the absolute and relative risks of missing a skin cancer when TBSE is not performed, as well as the number of patients needed to examine by TBSE to find a skin cancer. The secondary outcome was to assess the magnitude of false-positive results obtained by TBSEp-value: <0.0195% CI: [2.12, 2.62]Regression, Logistic
Secondary

Whether a Systematic Screening is Related to a Higher Number of Unnecessary Excisions of Benign Skin Tumors Detected During the Screening.

Time frame: one year

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026